Historically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.
Fiona Lee, PharmD Candidate
Advertisement
Articles by Fiona Lee, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Round-Up: Every Most Favored Nation Agreement With the Trump Administration
2
From the Pharmacy Counter to the Kitchen Cabinet: Helping Patients Choose Quality Supplements
3
Atebimetinib Signals a Potential Shift in First-Line Pancreatic Cancer Outcomes
4
Expert: Early Phase 1 Data Shows KTX-1001 Targeting NSD2 Offers Promise for Relapsed/Refractory Multiple Myeloma
5